ARTICLE | Company News
PhotoCure submits NDA for Hexvix
July 1, 2005 1:08 AM UTC
PhotoCure (OSE:PHO) submitted an NDA to FDA for Hexvix imaging agent to diagnose bladder cancer during cystoscopy. In March, Hexvix was approved in Europe to diagnose bladder cancer. ...